Literature DB >> 23810876

Lessons from the heart: troponin elevations in patients with established peripheral artery disease.

James A de Lemos1, Dharam J Kumbhani2.   

Abstract

Entities:  

Keywords:  endovascular; outcomes; peripheral artery disease; troponin

Mesh：

Substances：

Year:  2013        PMID： 23810876     DOI： 10.1016/j.jacc.2013.05.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.

Authors:  Dharam J Kumbhani; Ph Gabriel Steg; Christopher P Cannon; Kim A Eagle; Sidney C Smith; Shinya Goto; E Magnus Ohman; Yedid Elbez; Piyamitr Sritara; Iris Baumgartner; Subhash Banerjee; Mark A Creager; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2014-02-28       Impact factor: 29.983

2.  The heart matters in diabetes: 10-Year outcomes of peripheral artery disease.

Authors:  Thomas Mueller; Franz Hinterreiter; Werner Poelz; Meinhard Haltmayer; Benjamin Dieplinger
Journal:  SAGE Open Med       Date:  2017-11-13

3.  Midlife Cardiorespiratory Fitness and the Development of Peripheral Artery Disease in Later Life.

Authors:  Neil Keshvani; Benjamin Willis; David Leonard; Ang Gao; Laura DeFina; Mary M McDermott; Jarett D Berry; Dharam J Kumbhani
Journal:  J Am Heart Assoc       Date:  2021-12-02       Impact factor: 5.501

4.  Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease.

Authors:  Ahmed A Naiem; Robert James Doonan; Oren K Steinmetz; Kent S MacKenzie; Elie Girsowicz; Jason P Bayne; Daniel I Obrand; Heather L Gill
Journal:  Vascular       Date:  2021-08-16       Impact factor: 1.105

5.  Effect of Repeated Remote Ischemic Preconditioning on Peripheral Arterial Disease in Patients Suffering from Intermittent Claudication.

Authors:  Mehmet Balin; Tarık Kıvrak
Journal:  Cardiovasc Ther       Date:  2019-12-10       Impact factor: 3.023
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.